Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Epithelial cell states distinguish between uterine cancers
Fri December 3rd - Two epithelial cell states have been identified that can help to distinguish between types of uterine cancer, British researchers announced last night. More
COVID-19 boosters increase immunity
Fri December 3rd - Six different types of COVID-19 boosters are safe and increase immunity following vaccination with either the AstraZeneca or Pfizer-BioNTech jabs, British researchers report today. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...

Row as liver virus found in donated blood

Monday July 28th, 2014

There was controversy today over a study which revealed that thousands of blood donors are infected with a usually harmless liver virus.

British researchers who studied the prevalence of the hepatitis E virus said they did not believe it was necessary yet to screen blood donors.

But other experts disagreed.

The study of the virus was published for World Hepatitis Day today.

According to the researchers, people with suppressed immune systems, such as transplant patients, may contract persistent hepatitis E and be placed at risk of developing chronic liver disease.

The study, reported in The Lancet, found that about one in every 3,000 blood donors in England showed signs of infection with the virus.

This would mean some 1,200 blood components used in transfusions were infected with the virus.

The findings come from an analysis of some 225,000 donations in south-east England over 12 months period. Some 79 donors were infected - leading to some 62 donations being at risk.

The researchers found that 42% of patients who received the infected blood components contracted the virus - known as HEV.

Researcher Professor Richard Tedder, of Public Health England, said: "Our study indicates that the overall burden of harm resulting from transfusion-transmitted HEV is slight.

"Although on a clinical basis alone there appears no pressing need at this time for blood donations to be screened, a broader discussion over harm mitigation is now required."

He added: "HEV genotype 3 infections are widespread in the English population, including blood donors. We estimate that between 80 000 and 100 000 human HEV infections are likely to have occurred in England during the year of our study."

But, writing in the journal, Professor Jean-Michel Pawlotsky, from Hôpital Henri Mondor, Université Paris-Est, Créteil, France, said donated blood should be systematically screened for the virus.

He adds: "The potential clinical results of blood-borne HEV infection should not be downplayed; in particular, the risk of serious complications and death exists."

E virus in blood components: a prevalence and transmission study in southeast England. Lancet 28 July 2014 [abstract]

Tags: Flu & Viruses | Gastroenterology | Internal Medicine | UK News | World Health

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)